Orient EuroPharma Co., Ltd. (4120.TWO)
TWD 47.2
(-0.21%)
TWD 47.2
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.59 Billion | 4.73 Billion | 4.76 Billion | 5.38 Billion | 6.09 Billion |
| Cost of Revenue | 2.44 Billion | 2.69 Billion | 2.61 Billion | 2.96 Billion | 3.27 Billion |
| Gross Profit | 2.14 Billion | 2.03 Billion | 2.15 Billion | 2.42 Billion | 2.81 Billion |
| Operating Expenses | 2.14 Billion | 2.18 Billion | 2.24 Billion | 2.3 Billion | 2.47 Billion |
| Selling, General and Administrative Expenses | 1.86 Billion | 1.92 Billion | 1.91 Billion | 1.93 Billion | 746.51 Million |
| Research and Development Expenses | 206.59 Million | 259.84 Million | 331.09 Million | 366.55 Million | 394.6 Million |
| Other Expenses | - | -99.88 Million | 36.06 Million | 42.09 Million | 1.33 Billion |
| Cost and Expenses | 4.5 Billion | 4.88 Billion | 4.86 Billion | 5.26 Billion | 5.75 Billion |
| Operating Income | 84.55 Million | -259 Million | -57.76 Million | 284.23 Million | 336.41 Million |
| Interest Expense | 106.09 Million | 69.53 Million | 38.03 Million | 30.23 Million | 24.91 Million |
| Income Tax Expense | 86.96 Million | -32.76 Million | 10.47 Million | 143 Million | 228.23 Million |
| Earnings before Tax | 256.25 Million | -328.13 Million | 84.76 Million | 249.88 Million | 365 Million |
| Net Income | 143.94 Million | -310.8 Million | 120.17 Million | 199.3 Million | 247.66 Million |
| Earnings Per Share Basic | 1.66 | -3.58 | 1.39 | 2.30 | 2.86 |
| Earnings Per Share Diluted | 1.66 | -3.58 | 1.38 | 2.29 | 2.84 |
| Weighted Average Shares Outstanding | 86.74 Million | 86.74 Million | 86.74 Million | 86.74 Million | 87.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.94 Million | 86.74 Million | 86.95 Million | 87.14 Million | 87.08 Million |
| Gross Margin | 0.47 | 0.43 | 0.45 | 0.45 | 0.46 |
| EBIT Margin | 0.13 | -0.01 | 0.03 | 0.09 | 0.08 |
| Profit Margin | 0.03 | -0.07 | 0.03 | 0.04 | 0.04 |
| EBITDA | 582.93 Million | -34.14 Million | 133.32 Million | 493.8 Million | 484.03 Million |
| Earnings Before Tax Margin | 0.02 | -0.05 | -0.01 | 0.05 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.08 Billion | 1.1 Billion | 1.21 Billion | 4.59 Billion | 1.09 Billion | 1.13 Billion |
| Cost of Revenue | 556.69 Million | 576.33 Million | 591.71 Million | 2.44 Billion | 562.96 Million | 663.01 Million |
| Gross Profit | 529.37 Million | 527.99 Million | 621.53 Million | 2.14 Billion | 531.94 Million | 469.88 Million |
| Operating Expenses | 524.4 Million | 500.53 Million | 505.16 Million | 2.07 Billion | 510.43 Million | 564.53 Million |
| Selling, General and Administrative Expenses | 462.09 Million | 432.78 Million | 441.5 Million | - | 456.21 Million | 498.57 Million |
| Research and Development Expenses | 62.3 Million | 67.75 Million | 63.66 Million | - | 54.22 Million | 65.96 Million |
| Other Expenses | -538 Thousand | -54.51 Million | 343.37 Million | 259.14 Million | -31.74 Million | 7.69 Million |
| Cost and Expenses | 1.08 Billion | 1.07 Billion | 1.09 Billion | 4.51 Billion | 1.07 Billion | 1.22 Billion |
| Operating Income | 8.89 Million | -17.77 Million | 470.72 Million | 363.88 Million | -784 Thousand | -187.32 Million |
| Interest Expense | 25.74 Million | 24.97 Million | 27.34 Million | 106.09 Million | 27.52 Million | 26.46 Million |
| Income Tax Expense | 30.76 Million | 15.65 Million | 82.02 Million | 86.96 Million | 5.91 Million | -27.04 Million |
| Earnings before Tax | -18.28 Million | -55.02 Million | 443.15 Million | 256.25 Million | -28.79 Million | -214.98 Million |
| Net Income | -70.54 Million | -89.85 Million | 339.93 Million | 143.94 Million | -34.76 Million | -189.03 Million |
| Earnings Per Share Basic | -0.81 | -1.04 | 3.92 | - | -0.40 | -2.18 |
| Earnings Per Share Diluted | -0.81 | -1.04 | 3.91 | - | -0.40 | -2.18 |
| Weighted Average Shares Outstanding | 87.09 Million | 86.4 Million | 86.83 Million | 86.74 Million | 86.91 Million | 86.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 87.09 Million | 86.4 Million | 86.93 Million | 86.94 Million | 86.91 Million | 86.71 Million |
| Gross Margin | 0.49 | 0.48 | 0.51 | 0.47 | 0.49 | 0.41 |
| EBIT Margin | 0.06 | 0.03 | 0.43 | - | 0.05 | -0.12 |
| Profit Margin | -0.06 | -0.08 | 0.28 | 0.03 | -0.03 | -0.17 |
| EBITDA | 61.37 Million | 35.05 Million | 524.96 Million | - | 54.34 Million | -133.08 Million |
| Earnings Before Tax Margin | 0.01 | -0.02 | 0.39 | 0.08 | -0.00 | -0.17 |
CRRVF
6916
CASI
300166
LBTL
BRN